Cboe Global Markets shares climbed sharply during market hours today, rising +3.74% to trade at $339.18 and briefly reaching a new 52-week high of $340.50. The advance followed the companys first-quarter 2026 results, released on May 1, which outperformed expectations and prompted management to lift its full-year outlook.
For Q1 2026 Cboe reported adjusted earnings per share of $3.70 versus consensus expectations of $3.37, on revenue of $728.9 million. The company said net revenue was up 29% and adjusted diluted EPS rose 48% year over year. CFO Jill Griebenow highlighted the quarters momentum, saying: "Cboe delivered an exceptional first quarter, building on our 2025 momentum by producing 29 percent net revenue growth, 54 percent diluted EPS growth, and 48 percent adjusted diluted EPS growth."
Management also made notable changes to its full-year outlook and cost assumptions. Cboe increased its 2026 organic total net revenue growth target to a range described as "low double-digit to mid-teens" from a prior target of "mid single-digit." The company raised its Cboe Data Vantage organic net revenue growth target to "low double-digit" from "mid to high single-digit." At the same time, the firm trimmed its adjusted operating expense guidance for 2026.
As part of a strategic realignment, Cboe said it plans a roughly 20% workforce reduction expected to generate annualized pre-tax expense savings in the range of $100 million to $120 million. The company also completed a divestiture of its Canadian and Australian businesses to TMX Group for $300 million. The operating expense guidance was narrowed to $8380$853 million, down from the prior range of $8640$879 million, with management attributing the reduction in part to the strategic realignment.
Derivatives-related revenue showed strong performance in the quarter. Options net revenue increased 33% year over year. Cboe reported record average daily volume in index options of 6.1 million contracts, a 29% rise from the prior year, supported by ongoing activity in Zero-Days-to-Expiration (0DTE) SPX options.
Analysts reacted to the results and guidance changes with several upward price-target revisions. Barclays raised its target to $382 and maintained an Overweight rating. TD Cowen increased its target to $365 and kept a Hold rating. UBS and Keefe, Bruyette & Woods each moved their targets to $335. Goldman Sachs raised its target to $282 while maintaining a Sell rating.
Investors pushed Cboe shares higher even as the broader U.S. equity complex showed weakness. The S&P 500 was down -0.49%, the Dow Jones Industrial Average fell -0.89%, and the NASDAQ declined -0.48%, underscoring that Cboes move was driven by company-specific developments rather than a market-wide upswing. The note accompanying the earnings news also referenced recent insider selling reported at the same time, which could be viewed by some market participants as a cautionary signal.
Taken together, the combination of a record earnings beat, a meaningful guidance upgrade, explicit cost-reduction measures, and a cluster of analyst target increases pushed the stock to a new 52-week high. The narrowed adjusted operating expense range, when coupled with robust revenue growth, positions the company for potential margin expansion during the year, according to the companys public guidance.
While the broader market was a headwind today, Cboes quarterly performance and the accompanying strategic actions were sufficient to drive a company-specific rally. Market participants will likely monitor execution of the workforce reduction and the realization of the projected pre-tax savings, as well as the contribution of divested assets and continued derivatives volume trends, particularly in 0DTE SPX options.